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Background: Exposure to diesel exhaust causes inflammatory responses. Previous controlled exposure studies at a
concentration of 300 μg/m3 of diesel exhaust particles mainly lasted for 1 h. We prolonged the exposure period
and investigated how quickly diesel exhaust can induce respiratory and systemic effects.
Methods: Eighteen healthy volunteers were exposed twice to diluted diesel exhaust (PM1 ~300 μg/m3) and twice
to filtered air (PM1 ~2 μg/m3) for 3 h, seated, in a chamber with a double-blind set-up. Immediately before and after
exposure, we performed a medical examination, spirometry, rhinometry, nasal lavage and blood sampling. Nasal
lavage and blood samples were collected again 20 h post-exposure. Symptom scores and peak expiratory flow
(PEF) were assessed before exposure, and at 15, 75, and 135 min of exposure.
Results: Self-rated throat irritation was higher during diesel exhaust than filtered air exposure. Clinical signs of
irritation in the upper airways were also significantly more common after diesel exhaust exposure (odds ratio=3.2,
p<0.01). PEF increased during filtered air, but decreased during diesel exhaust exposure, with a statistically
significant difference at 75 min (+4 L/min vs. -10 L/min, p=0.005). Monocyte and total leukocyte counts in
peripheral blood were higher after exposure to diesel exhaust than filtered air 20 h post-exposure, and a trend
(p=0.07) towards increased serum IL-6 concentrations was also observed 20 h post-exposure.
Conclusions: Diesel exhaust induced acute adverse effects such as symptoms and signs of irritation, decreased PEF,
inflammatory markers in healthy volunteers. The effects were first seen at 75 min of exposure.
Keywords: Diesel exhaust, Chamber experiment, Lung function, Biomarkers, Respiratory inflammationBackground
The adverse health effects of particulate air pollution are
well documented [1-5], and urban outdoor air pollution
was estimated to cause 1.34 million premature deaths
worldwide in 2008, an increase of 16% from 2004 [6].
Diesel exhaust (DE) emissions constitute, according to
estimates from the USA, 4-16% of the total particulate
matter (PM) in non-urban and urban areas [7,8]. People
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reproduction in any medium, provided the orroadways are more likely to have irritant respiratory
symptoms and reduced baseline pulmonary function
[9,10], and to develop respiratory disease including allergy
[11], chronic obstructive pulmonary disease [12,13], and
lung cancer [14-16].
Epidemiological studies have shown associations between
DE and respiratory diseases, but the underlying mecha-
nisms are still not fully understood and the exposure
needs to be better characterized to improve the basis for
risk assessment in occupational and environmental settings.
Part of this knowledge gap was filled by a series of con-
trolled human diesel exhaust exposure studies carried
out in Umeå, Sweden. They monitored exposure, andThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Exposure details during DE and FA exposures
DE exposure FA exposure
PM1 mass concentration (μg/m3) 276±27 2±2
Number concentration (particles/cm3) 388000±48000 14±16
NO (ppm) 9.8±1.0 0.003±0.001
NO2 (ppm) 1.3±0.4 0.002±0.001
CO2 (ppm) 1945±125 947±67
Formaldehyde (μg/m3) 400±97 7.5
Temperature (°C) 22.7±0.7 22.7±0.8
Values are mean ± standard deviation (SD).
DE, diesel exhaust; FA, filtered air.
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Healthy and asthmatic volunteers were exposed in an ex-
posure chamber to either DE concentrations of 300 μg/m3
(measured as PM10) for 1 h [17-19] or 100 μg/m
3 for 2 h
[20,21]. The results demonstrated that DE exposure caused
inflammatory responses at 6 h and 18 h. This was indicated
by increased cell counts (neutrophils, B lymphocytes and
eosinophils) and concentrations of fibronectin and methyl
histamine in airway lining fluid, as well as increase neutro-
phils and mast cells, up-regulation of endothelial adhesion
molecules and interleukins in bronchial biopsies [17-19,22].
In one experiment, this airway inflammation was also
followed by an increase of neutrophils and platelets in
peripheral blood [19].
Additionally, a DE-induced bronchoconstrictive response
(increased airway resistance and specific airway resistance)
was observed as measured by computerized whole body
plethysmography [20,23,24]. However, no significant change
was detected with conventional pulmonary function tests
(dynamic spirometry and peak expiratory flow) [19,25].
The Umeå studies have provided extensive knowledge on
the respiratory effects of moderate DE exposure. However,
the absence of lung function changes in conventional tests
in most of the Umeå studies may be due to the relatively
short exposure time and follow-up time. In the present
investigation, which is a part of the DINO study “Health
Effects of Combined Exposure to Diesel and Noise”, we
prolonged the exposure time to 3 h and monitored symp-
toms and peak expiratory flow (PEF) over the whole ex-
posure period. The aim was to find potential relationships
between exposure and effects, and to monitor how quickly
such changes would develop.
Materials and methods
Subjects
Eighteen healthy, non-smoking volunteers (9 males and
9 females) with a mean age of 51 (range 40–66) years were
recruited. Inclusion criteria were no symptoms or diagnosis
of asthma, normal chest auscultation, lung function and a
negative skin prick test to a standard panel of aeroallergens
for atopy. The study was approved by the Regional Ethical
Review Board, and all subjects provided written consent.
Exposure protocol
Each subject underwent four different exposure scenarios at
rest (seated quietly): (1) Reference exposure: low DE concen-
tration (measured as mass concentration of particles with an
aerodynamic diameter less than 1 μm, PM1 ~2 μg/m
3) and
low traffic noise (46 dB(A)); (2) Diesel exposure: high
DE concentration (PM1 ~300 μg/m
3) and low traffic noise;
(3) Noise exposure: low DE concentration and high traffic
noise (75 dB(A)); and (4) Diesel and noise exposure: high
DE concentration and high traffic noise. Exposure lasted
for 3 h and took place in a specially built exposure chamber(22 m2, suitable for 3 persons simultaneously) on different
occasions in a randomized sequence, at least one week
apart. The study design was double-blind, however, the
difference between high and low traffic noise was easily
noticed by study subjects and the physician.
In this paper, the reference exposure and the noise
exposure were merged and renamed “filtered air” (FA)
exposure, while the diesel exposure and the diesel and
noise exposure were merged and renamed “diesel exhaust”
(DE) exposure, since no interactions were found be-
tween DE and noise in any marker of respiratory effects
(see Statistical analysis section).
The DE was generated from a passenger car (Volkswagen
Passat TDI, -98, 1900 cm3, 81 kW) running in idle mode.
Swedish Environmental Class 1 diesel fuel with a sulfur
content less than 10 ppm was used. Dilution was con-
trolled to supply the desired concentration of particles
to the chamber for the different exposure scenarios.
Details of diesel aerosol generation, as well as DE character-
istics in both particle and gas phase are reported elsewhere
[26]. Traffic noise recorded at a street crossing was played
from two loudspeakers reproducing each channel in a ste-
reo recording. The noise had a continuous, natural change
of noise level. The temperature and the relative humidity in
the chamber were maintained at 23°C and between 30%
and 40%, respectively. Characteristics of DE and FA expo-
sures are presented in Table 1.
Self-reported symptoms and medical examinations
The questions about symptoms of upper airways, in-
cluding runny nose, nasal congestion, throat irritation
and chest tightness, were rated on a visual analogue
scale (VAS) (range 0 to 100 millimeter) before expos-
ure, and at 15, 75 and 135 min into exposure during
each exposure session. The VAS is most appropriate at
repeated measurement within subjects as it has the
sensitivity required to measure minute changes [27]. Signs
of nose and throat irritation (redness/secretion/swelling)
were recorded (normal/slight/moderate/pronounced),
and auscultation of lungs was performed in a medical
examination before and after exposure by the same
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plings see Table 2.
Lung function and nasal patency
PEF was measured in two ways: (1) PEF data output
from a Mini-Wright Peak Flow Meter (MWPFM) with a
measuring range of 60–800 L/min, which was measured
four times (three recordings each time) in each exposure
session: before exposure and at 15, 75 and 135 min into
exposure; (2) PEF data output from a computerized spir-
ometer (SPIRARE 3, DIAGNOSTICA, Oslo, Norway),
which was measured only before and after exposure
(three recordings each time).
Rhinometry and spirometry (a minimum of three re-
cordings for each outcome) were performed before and
after exposure: forced vital capacity (FVC) and forced
expiratory volume in one second (FEV1) were measured
according to the European Respiratory Society guidelines
[28], using the computerized spirometer. The minimal
cross-sectional area between 0–22 mm (MCA1) and be-
tween 22–54 mm (MCA2) into the nasal opening, and
the volume of the nasal cavity between these distances
(Volume1 and Volume2) were determined using acoustic
rhinometry (RhinoScan v. 2.5, Interacoustics A/S,
Assens, Denmark) [29]. The “best” results at each time
point from PEF, spirometry and acoustic rhinometry
measurements were included in the statistical analysis.
Nasal lavage
Nasal lavage was performed in this study since it has
been proposed as a noninvasive method to detect upper
airway inflammation of air pollutants [30,31]. We con-
ducted nasal lavage before exposure, after exposure, and
at 20 h post-exposure (range 18–22 h), with minor mod-
ifications as described by Benson et al. [32]. Briefly, 18
ml 37°C 0.9% NaCl solution was instilled with a syringe
into one nostril until the liquid appeared in the opposite
one. The liquid was sucked back and instilled again. The
procedure was repeated three times in each nostril. The
lavage liquid was immediately chilled and the cells were




15 min 75 mi
Self-rating symptoms × (7:40) × (9:45) × (10:4
Medical examination × (7:00)
Peak expiratory flow × (7:40) × (9:45) × (10:4
Rhinometry × (8:30~9:00)
Spirometry × (8:30~9:00)
Blood samples × (8:30~9:00)
Nasal lavage × (8:30~9:00)AG, Hamburg, Germany). The supernatant was separated
from the pellet and stored at −80°C until analysis of in-
flammatory markers.
Inflammatory markers in blood and nasal lavage
Peripheral blood samples (before exposure, after exposure,
20 h post-exposure) were analyzed for total and differential
leukocyte cell counts (Sysmex XE-1800i). Plasma fibrinogen
(Sysmex CA-7000) and C reactive protein (CRP, Cobas c501)
concentrations were determined.
The serum concentrations of interleukin-6 (IL-6) and
IL-8, and the nasal lavage concentrations of IL-6, IL-8,
intercellular adhesion molecule-1 (ICAM-1) and tumor
necrosis factor-α (TNF-α) were analyzed by multiplexed
magnetic bead-based immunoassays on a Luminex platform
(Bio-Plex 200, Bio-Rad Life Science, Hercules, CA).
Clara cell protein (CC16) and surfactant protein D
(SP-D) in serum were analyzed using commercial ELISA
kits from Biovendor (BioVendor Laboratory Medicine,
Inc., Brno, Czech Republic), according to the protocols
supplied by the manufacturer. The imprecision, expressed
as coefficient of variation, was 13% for CC16 and 12% for
SP-D, as calculated from duplicate analyses.
Statistical analysis
Absolute changes from baseline were calculated for each
individual and each exposure scenario to reduce the
influence of inter-individual variation for the data from
self-rated symptoms, lung function, biomarkers in blood
and nasal lavage. Then the four exposure scenarios were
merged into two, as explained above, since the effect of
noise did not modify the effect of DE in any of the
markers (p>0.06 for all); the variation of the mean PM1
mass concentrations between all DE exposures (i.e. the
diesel exposures and the diesel and noise exposures)
from the mean value of 276 μg/m3 (Table 1) was on
average smaller than 6.5%. The changes in the selected
outcome measures at DE exposure vs. changes at FA
exposure were analyzed with repeated-measures analysis
of variance using a linear model type of the generalized
estimating equation in SPSS 18.0 (SPSS Inc., Chicago,blood and nasal lavage samplings










× (13:20~13:50) × (7:00~8:30)
× (13:20~13:50) × (7:00~8:30)
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scenarios, and the time point of measurements were used
to indicate the repeated measurements. Exposure sequence
was not included in the final models since inclusion of the
exposure sequence did not change the results.
The data from the medical examination was transformed
to binary variables. If signs (redness/secretion/swelling of
nose, throat, and sound of lung and heart auscultation)
after exposure became worse than before exposure
(from normal to slight, and so on), we recorded it as
“getting worse”, otherwise “no change”. Any “getting worse”
sign of nose and throat, or sound of lungs represented
a corresponding positive finding of upper-airway irritation
or lung signs. A binary logistic model type of generalized
estimating equation was used to estimate the odds ratios.
Statistical significance refers to p<0.05 (two-tailed).
However, multiple comparisons were performed for
self-rated symptoms (three times), PEF from MWPFM
(three times), and inflammatory markers in blood and
nasal lavage (two times). For those comparisons, statis-
tical significance refers to p<0.017 and p<0.025, re-
spectively, according to the Bonferroni correction.
Results
Symptoms and Signs
Scores of self-rated symptoms are presented in Table 3.
Subjects reported a mild but progressive irritation in the
throat during DE exposure, the increment on the VAS
scale was 3.75 in DE exposure versus −1.53 in FA exposure
(p=0.016) at 135 min. No significant differences between ex-
posures were detected in self-rated nose or chest symptoms.
Irritation in upper airways (nose and throat) was found in
the physical examination. Exposure to DE increased the
odds ratio (OR) of signs in the upper-airways (OR=3.2, 95%
CI 1.9-11.0). No change was found in lung sounds (data
not shown).Table 3 Effects of FA exposure and DE exposure on self-rated
Before exposure 15 min exposure 75 min expo
FA exposure
Runny nose 1.39±7.83 0.08±0.5 0.14±0.8
Nasal congestion 1.69±7.99 0.53±1.18 0.61±1.8
Throat irritation 1.66±7.46 1.00±5.01 0.11±0.4
Chest tightness --* --* --*
DE exposure
Runny nose 2.86±10.91 1.97±10.09 1.44±7.6
Nasal congestion 3.03±10.55 1.72±7.52 2.69±8.0
Throat irritation 2.31±6.96 1.06±2.27 4.00±8.6
Chest tightness 0.28±1.67 0.17±0.74 0.17±0.7
Values are mean ± standard deviation (SD) using a visual analog scale.
DE, diesel exhaust; FA, filtered air.
aΔ 15 min = 15 min of exposure – before exposure; Δ 75 min = 75 min of exposure
*No symptoms were reported. #P <0.017 for DE exposure vs. FA exposure.Lung function
Similar PEF values at baseline were obtained with the
MWPFM and the spirometer for both FA and DE exposure
(Table 4). However, after 15 min of exposure, PEF decreased
during DE exposure but increased during FA exposure, and
this pattern lasted throughout the whole exposure period.
The difference between PEF changes in DE and FA was
14 L/min at 75 min of exposure (MWPFM, p=0.005), 12
L/min at 135 min of exposure (MWPFM, p=0.020) and
10 L/min after exposure (spirometer, p=0.078) (Table 4).
The changes in spirometry (FEV1, FVC) and rhinometry
results were small and similar after both DE and FA expos-
ure (Table 5).
Inflammatory markers
There was a significantly greater increment of total
leukocytes in blood at 20 h post-exposure following DE
exposure compared to FA exposure (Table 6, p=0.007),
including a significantly higher increment of monocyte
counts (p=0.017). A trend towards an increase in mono-
cyte counts between DE exposure and FA exposure was
suggested also immediately after exposure (p=0.04). No
such patterns were discerned for neutrophils, eosino-
phils or lymphocytes.
Data on other inflammatory markers in serum and
nasal lavage are shown in Table 7. We only found a
significant difference between CC16 changes in DE
and FA exposure. A slight increase in CC16 was ob-
served immediately after DE exposure and returned to
baseline at 20 h post-exposure for DE exposure, while
it increased at 20 h post-exposure of FA exposure
(p=0.016). A trend towards a greater increment of
serum IL-6 for DE exposure than FA exposure was
suggested at 20 h post-exposure (p=0.066). However,
CRP tended to decrease more rapidly after exposure
to DE than after FA (p=0.034).symptoms
sure 135 min exposure Δ 15 mina Δ 75 mina Δ 135 mina
3 0.00±0.00 −1.31±7.86 −1.25±7.88 −1.39±7.83
7 0.36±1.36 −1.17±8.12 −1.08±8.21 −1.33±8.11
6 0.08±0.50 −0.61±8.64 −1.50±7.03 −1.53±7.36
0.14±0.83 --* --* 0.14±0.83
6 1.69±8.34 −0.89±3.44 −1.42±4.86 −1.17±4.31
8 3.53±9.32 −1.31±4.33 −0.33±8.10 0.50±6.98
4 6.06±12.11 −1.25±6.21 1.69±10.32 3.75±12.11#
4 0.56±2.29 −0.11±1.51 −0.11±1.85 0.28±2.88
– before exposure; Δ 135 min = 135 min of exposure – before exposure.




















PEF (L/min) from MWPFM 530±73 533±73 534±73 538±75 --* 3±25 4±26 8±31 --*
PEF (L/min) from spirometer 524±88 --* --* --* 531±90 --* --* --* 8±27
DE exposure
PEF (L/min) from MWPFM 537±74 531±75 528±78 534±81 --* −6±22 −10±22 # −4±18 --*
PEF (L/min) from spirometer 530±93 --* --* --* 527±89 --* --* --* −3±24
Values are mean ± standard deviation (SD).
DE, diesel exhaust; FA, filtered air; PEF, peak expiratory flow; MWPFM, Mini-Wright Peak Flow Meter.
aΔ 15 min = 15 min of exposure – before exposure; Δ 75 min = 75 min of exposure – before exposure; Δ 135 min = 135 min of exposure – before exposure;
Δ after exposure = after exposure – before exposure.
*No PEF was recorded. #P <0.017 for DE exposure vs. FA exposure.
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This study was extracted from DINO project, the overall
aim of which was to evaluate the combined effect of
DE and traffic noise on human physiological response
(including also cardiovascular responses such as heart
rate variability). Although effects of traffic noise on airways
have not been documented, we still initially included traffic
noise in the analysis, to see if it modified the reported
or observed airway effects of DE. However, no such
modifying effect was found in any markers of respiratory
response. Moreover, the generation of DE was highly repro-
ducible between the sessions. Thus, for optimal statistical
power, we merged the four exposures into two: exposure or




FEV1 FA exposure 3.23±0.57
DE exposure 3.23±0.60
FVC FA exposure 4.12±0.71
DE exposure 4.13±0.72
Rhinometry
MCA1 FA exposure 1.12±0.28
DE exposure 1.08±0.24
MCA2 FA exposure 0.95±0.23
DE exposure 0.94±0.20
Volume1 FA exposure 4.06±0.75
DE exposure 4.05±0.72
Volume2 FA exposure 6.90±1.56
DE exposure 6.51±1.19
Values are mean ± standard deviation (SD).
DE, diesel exhaust; FA, filtered air; FEV1, forced expiratory volume in one second; FV
MCA2, minimal cross-sectional area between 22–45 mm.
aΔ after exposure = after exposure – before exposure.The concentration of DE in this study was nearly
300 μg/m3, and such levels may occur at rush hours in
large city centers. We found divergent trends in PEF
changes during DE and FA exposure, and a significant
DE-associated PEF decrease at 75 min in healthy subjects.
Self-reported symptoms and the physical examination
indicated irritation of the upper airways. The increase
in peripheral leukocyte counts suggests a mild systemic
inflammatory response, supported also by a tendency
towards an increase in serum IL-6.
To the best of our knowledge, this is the first study that
shows an effect on PEF in healthy subjects. DE induced
a slight but consistent reduction in PEF that was signifi-
cantly different from FA exposure at 75 min. Thereaftertry (FEV1, FVC) and rhinometry (MCA1, MCA2,













C, forced vital capacity; MCA1, minimal cross-sectional area between 0–22 mm;
Table 6 Effects of FA exposure and DE exposure on cell count in peripheral blood
Cell type Cell count (×109/L) P-values for
















Leukocytes 5.45±1.36 5.72±1.34 5.17±1.17 0.27±0.53 −0.28±1.02 – –
Neutrophils 3.02±1.15 2.99±1.03 2.64±0.75 −0.04±0.31 −0.38±0.99 – –
Eosinophils 0.19±0.09 0.20±0.11 0.21±0.11 0.01±0.06 0.02±0.06 – –
Lymphocytes 1.69±0.49 2.02±0.64 1.83±0.53 0.33±0.32 0.14±0.30 – –
Monocytes 0.49±0.13 0.48±0.15 0.44±0.12 −0.01±0.13 −0.05±0.11 – –
DE exposure
Leukocytes 5.29±1.00 5.60±0.98 5.45±1.37 0.31±0.55 0.16±1.01 0.725 0.007
Neutrophils 3.00±0.81 2.91±0.63 2.89±1.04 −0.09±44 −0.11±0.93 0.474 0.139
Eosinophils 0.19±0.12 0.20±0.13 0.22±0.13 0.01±0.06 0.03±0.07 0.847 0.431
Lymphocytes 1.59±0.48 1.94±0.59 1.82±0.64 0.35±0.24 0.23±0.35 0.651 0.264
Monocytes 0.47±0.11 0.51±0.10 0.48±0.13 0.04±0.11 0.01±0.10 0.042 0.017
Values are mean ± standard deviation (SD).
DE, diesel exhaust; FA, filtered air.
aΔ after exposure = after exposure – before exposure; Δ 20 h post-exposure = 20 h post-exposure – before exposure.
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exposure, approaching significance. Our interpretation
is that DE caused a transient lung function change with
rapid recovery. PEF was seldom measured at DE exposure
in healthy volunteers, but in asthmatics exposed to DE
(PM10 100 μg/m
3) for 2 h, there was a non-significant
trend towards a decreased PEF immediately after exposure
[33]. Similar to other studies [20,34], we performed spirom-
etry before and after exposures and failed to find significant
difference in FEV1 changes, although we used a longer ex-
posure time (3 h). This also reflected that the time points of
monitoring may be important. In this study, there was a 50
min delay between end of exposure and spirometry, which
may allow the lung function to recover. Moreover, the
subjects of this study were older (mean age about 50 years)
than in other studies.
The small but significant PEF changes in healthy subjects
may imply that occupational DE limit values should be
reconsidered. DE is quite common in occupational set-
tings, and some studies have indicated adverse effects
on lung function at long-term occupational exposure
to DE in combination with dust [10,35]. The current
American Conference of Governmental Industrial Hygienists
(ACGIH) Threshold Limit Values (TLVs) for respirable
particulates and NO2 are 3 mg/m
3 and 3 ppm as 8-hour
time-weighted averages (TWAs), respectively [36]. How-
ever, the present study indicates that substantially lower
exposures (PM1 level of 300 μg /m
3 and NO2 of 1.3 ppm)
to DE for only three hours will cause a transient effect
on lung function.As in previous studies [23,37], self-reported throat and
eye irritation [26] increased during DE exposure, in
agreement with objective signs at the physical examin-
ation. The emission of aldehydes is the most likely cause
in the present study. A Swedish study found an increase
in nasal irritation and lower respiratory tract symptoms
at an average exposure of 260 μg/m3 of formaldehyde
[38]. Our exposure level of formaldehyde, about 400 μg/m3,
was higher than in these reports, and DE also contains
other aldehydes such as acrolein that may cause such irri-
tant symptoms.
In the present study, we used nasal lavage for measure-
ment of the acute cytokines (IL-6, IL-8, TNF-α, ICAM-1)
to define the timing of inflammatory response in the nasal
cavity instead of the more invasive bronchoalveolar lavage
and bronchoscopy techniques. However, such repeated
sampling of airway fluid could have the drawback of
washout effect [30,39], resulting in lower concentration
of biomarkers in subsequent lavages and then diminish-
ing real differences between DE and FA exposures. The
only finding in nasal lavage in this study was a slight
increase (not statistically significant) of IL-6 after DE
exposure at 20 h post-exposure. Other cytokines (IL-8,
TNF-α, ICAM-1), on the contrary, remained unchanged.
Nasal lavage has not been widely investigated in chamber
studies of DE exposure, Blomberg et al. [40] only found
an increase in ascorbic acid concentration in nasal lavage
after diesel exposure (1 h, PM 300 μg/m3). In other in vivo
studies, intranasal challenge with allergen + DE in atopic
subjects was found to increase IgE, IL-4 and histamine
Table 7 Effects of FA exposure and DE exposure on inflammatory markers
Inflammatory
markers
Concentration of markers P-values for
















Serum IL-6 (pg/ml) 1.73±0.98 1.69±1.13 1.60±1.33 −0.04±0.56 −0.13±0.90 – –
Serum IL-8 (pg/ml) 5.00±3.28 4.91±3.26 5.46±4.35 −0.09±1.33 0.46±2.48 – –
NL IL-6 (pg/ml) 0.97±1.01 0.94±0.86 0.85±0.68 −0.03±0.93 −0.11±0.81 – –
NL IL-8 (pg/ml) 67.0±73.3 48.5±50.5 49.9±66.6 −18.6±71.5 −17.1±49.4 – –
NL TNF-α(pg/ml) 0.95±0.77 0.84±0.14 1.03±0.88 −0.10±0.79 0.08±1.19 – –
NL ICAM-1(pg/ml) 76.8±87.1 76.6±101 62.0±73.9 −0.15±114 −14.7±64.0 – –
CRP (mg/l) 1.6±1.6 1.5±1.7 1.3±1.2 −0.03±0.23 −0.27±0.54 – –
Fibrinogen (g/l) 2.9±0.5 2.9±0.5 3.1±0.6 0.12±0.72 0.24±0.66 – –
CC16 (μg/l) 5.93±1.98 5.84±2.20 6.73±2.38 −0.08±0.99 0.61±1.56 – –
SP-D (μg/l) 66.9±34.0 66.7±35.0 70.8±36.1 −0.21±9.42 3.90±9.81 – –
DE exposure
Serum IL-6 (pg/ml) 1.80±1.35 1.64±1.14 1.92±1.56 −0.16±0.64 0.12±0.78 0.413 0.066
Serum IL-8 (pg/ml) 5.10±3.62 4.85±3.79 5.59±3.74 −0.25±1.90 0.49±1.82 0.666 0.940
NL IL-6 (pg/ml) 1.32±2.03 1.29±2.08 2.01±5.04 −0.03±2.35 0.70±4.64 0.983 0.247
NL IL-8 (pg/ml) 71.3±71.7 63.9±97.8 48.6±46.7 −7.40±98.4 −22.7±48.1 0.483 0.597
NL TNF-α (pg/ml) 0.82±0.00 0.90±0.37 0.98±0.79 0.08±0.37 0.16±0.79 0.312 0.715
NL ICAM-1(pg/ml) 109.7±138 93.5±142 85.3±103 −16.2±114 −24.4±74.5 0.409 0.398
CRP (mg/L) 2.0±2.2 1.9±2.0 1.6±1.6 −0.12±0.24 −0.39±0.71 0.034 0.283
Fibrinogen (g/l) 3.2±0.7 3.3±0.8 3.4±01.0 0.13±0.55 0.26±0.84 0.968 0.940
CC16 (μg/l) 6.21±2.23 6.64±3.44 6.12±2.32 0.43±2.50 −0.09±1.44 0.224 0.016
SP-D (μg/l) 63.4±34.0 61.9±32.7 66.7±32.8 −1.45±4.78 3.34±12.1 0.626 0.838
Values are mean ± standard deviation (SD).
DE, diesel exhaust; FA, filtered air; NL, nasal lavage.
aΔ after exposure = after exposure – before exposure; Δ 20 h post-exposure = 20 h post-exposure – before exposure.
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of IL-6, IL-8 were not altered by intranasal challenge with
DE alone in healthy volunteers [43].
CC16 is an anti-inflammatory protein secreted by the
Clara cells located in the bronchioli [44], and the transfer
to serum is increased when the permeability of the lung
epithelial barrier is compromised [45]. Two chamber stud-
ies found increased serum CC16 after exposure to wood
smoke at PM mass concentrations similar to those in the
present study [46,47]. CC16 levels were, however, seldom
reported at DE exposure in previous chamber studies. In
this study, the slight increase of serum CC16 immediately
after DE exposure was not statistically significant and
levels returned to baseline at 20 h post-exposure. The
reason for the increase in serum CC16 the morning
after FA exposure is unclear.
DE exposure, at the moderate levels used in this study,
induced a systemic inflammatory response in peripheralblood. Previous experimental studies showed white cell
and proinflammatory cytokines changes in bronchoalveolar
lavage and bronchial biopsies, but rarely in peripheral
blood. Total leukocyte counts were higher after 3 h ex-
posure to both DE and FA in the afternoon than before
exposure in the morning, which reflects the normal
circadian variation [48]. However, the total leukocyte
counts remained increased at 20 h post-exposure after
DE exposure, but not after FA exposure, which suggests
a slight systemic cellular inflammatory response after ex-
posed to DE. Changes in pro-inflammatory cytokines in
peripheral blood were also identified. The trend towards
an increase of serum IL-6 (p=0.07) after DE exposure at
20 h post-exposure, which was also observed by Tornqvist
et al. [49], may represent a pro-inflammatory systemic re-
sponse. However, consistent with other controlled DE
chamber studies performed in either healthy volunteers
[50,51] or individuals with chronic obstructive pulmonary
Xu et al. Particle and Fibre Toxicology 2013, 10:60 Page 8 of 9
http://www.particleandfibretoxicology.com/content/10/1/60disease [52], we did not find a DE-associated increase in
CRP. The follow-up time in the present study perhaps has
been too short to detect a change in CRP.
Conclusion
In summary, this study shows that short-term exposure
to DE at 300 μg/m3 can cause irritation in upper air-
ways, along with a temporary decline in PEF in healthy
subjects, after only 75 min into exposure. Additionally,
the increase in leukocyte cell counts in peripheral blood
indicates that these levels of DE exposure also cause a
systemic inflammatory response.
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